Pre-Filled Syringes Conference 2011

The global pre-filled syringe market has seen rapid growth in recent years with the development of new treatments and formulations to treat a wide range of acute and chronic conditions.
From a pharma perspective, the benefits in increased patient compliance, market share and price premium are obvious - recent reports have estimated a total of 2 billion syringes being sold in 2009 with a total market size of up to US$2.5bn which is growing at 10-15% per year. Contributing to this growth are a number of factors including the rising number of injectable biotherapeutics, increasing patient/physician demands for convenient and safe containers, and spiralling healthcare costs which have led to a rising trend in drug self-administration and has introduced a range of naive users to parenteral drug delivery.
SMi's third annual conference on Pre-Filled Syringes will cover the current status of this industry and look beyond to the next generation of advanced injection devices in an interactive, case study led environment.